218 related articles for article (PubMed ID: 22402319)
1. Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception.
Oguchi T; Funahashi Y; Yokoyama H; Nishizawa O; Goins WF; Goss JR; Glorioso JC; Yoshimura N
Gene Ther; 2013 Feb; 20(2):194-200. PubMed ID: 22402319
[TBL] [Abstract][Full Text] [Related]
2. HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain.
Hao S; Mata M; Glorioso JC; Fink DJ
Mol Pain; 2006 Feb; 2():6. PubMed ID: 16503976
[TBL] [Abstract][Full Text] [Related]
3. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.
Geller AI; Keyomarsi K; Bryan J; Pardee AB
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8950-4. PubMed ID: 2174168
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model.
Jarnagin WR; Delman K; Kooby D; Mastorides S; Zager J; Brennan MF; Blumgart LH; Federoff H; Fong Y
Ann Surg; 2000 May; 231(5):762-71. PubMed ID: 10767798
[TBL] [Abstract][Full Text] [Related]
5. Statin administration ameliorates ischemia-induced overactive bladder with improvement of blood flow and anti-inflammatory effects in rats.
Ishizuka Y; Satake Y; Kimura S; Yamashita S; Kawamorita N; Ito A
Neurourol Urodyn; 2024 Apr; 43(4):991-1002. PubMed ID: 38426742
[TBL] [Abstract][Full Text] [Related]
6. Response to "Unilateral Periganglionic Resiniferatoxin (RTX) for Personalized Pain Treatment".
Beutler AS; Unger MD; Banck MS; Maus TP
Pain Med; 2021 Mar; 22(3):768-769. PubMed ID: 33200173
[No Abstract] [Full Text] [Related]
7. Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity.
Miyagawa Y; Marino P; Verlengia G; Uchida H; Goins WF; Yokota S; Geller DA; Yoshida O; Mester J; Cohen JB; Glorioso JC
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1632-41. PubMed ID: 25775541
[TBL] [Abstract][Full Text] [Related]
8. Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.
Duebgen M; Martinez-Quintanilla J; Tamura K; Hingtgen S; Redjal N; Wakimoto H; Shah K
J Natl Cancer Inst; 2014 Jun; 106(6):dju090. PubMed ID: 24838834
[TBL] [Abstract][Full Text] [Related]
9. Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.
Grünwald GK; Vetter A; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Wagner E; Göke B; Holm PS; Ogris M; Spitzweg C
J Nucl Med; 2013 Aug; 54(8):1450-7. PubMed ID: 23843567
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of antinociceptive gene therapies in animal models of diabetic neuropathic pain.
Wang Y; Nowicki MO; Wang X; Arnold WD; Fernandez SA; Mo X; Wechuk J; Krisky D; Goss J; Wolfe D; Popovich PG; Lawler S; Chiocca EA
Gene Ther; 2013 Jul; 20(7):742-50. PubMed ID: 23235561
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus vector mediated gene therapy of tumor necrosis factor-α blockade for bladder overactivity and nociception in rats.
Funahashi Y; Oguchi T; Goins WF; Gotoh M; Tyagi P; Goss JR; Glorioso JC; Yoshimura N
J Urol; 2013 Jan; 189(1):366-73. PubMed ID: 23174234
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention gene therapy (CGT): novel combinatorial approach for preventing and treating pancreatic cancer.
Sarkar S; Azab BM; Das SK; Quinn BA; Shen X; Dash R; Emdad L; Thomas S; Dasgupta S; Su ZZ; Wang XY; Sarkar D; Fisher PB
Curr Mol Med; 2013 Aug; 13(7):1140-59. PubMed ID: 23157679
[TBL] [Abstract][Full Text] [Related]
13. Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.
Grünwald GK; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Göke B; Holm PS; Spitzweg C
Gene Ther; 2013 Jun; 20(6):625-33. PubMed ID: 23038026
[TBL] [Abstract][Full Text] [Related]
14. Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors.
Tamura K; Wakimoto H; Agarwal AS; Rabkin SD; Bhere D; Martuza RL; Kuroda T; Kasmieh R; Shah K
Mol Ther; 2013 Jan; 21(1):68-77. PubMed ID: 22929661
[TBL] [Abstract][Full Text] [Related]
15. Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats.
Majima T; Funahashi Y; Takai S; Goins WF; Gotoh M; Tyagi P; Glorioso JC; Yoshimura N
Hum Gene Ther; 2015 Nov; 26(11):734-42. PubMed ID: 26204493
[TBL] [Abstract][Full Text] [Related]
16. Current gene therapy using viral vectors for chronic pain.
Guedon JM; Wu S; Zheng X; Churchill CC; Glorioso JC; Liu CH; Liu S; Vulchanova L; Bekker A; Tao YX; Kinchington PR; Goins WF; Fairbanks CA; Hao S
Mol Pain; 2015 May; 11():27. PubMed ID: 25962909
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 10 mediated by herpes simplex virus vectors suppresses neuropathic pain induced by human immunodeficiency virus gp120 in rats.
Zheng W; Huang W; Liu S; Levitt RC; Candiotti KA; Lubarsky DA; Hao S
Anesth Analg; 2014 Sep; 119(3):693-701. PubMed ID: 25137003
[TBL] [Abstract][Full Text] [Related]
18. Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin.
Guedon JM; Zhang M; Glorioso JC; Goins WF; Kinchington PR
Gene Ther; 2014 Jul; 21(7):694-702. PubMed ID: 24830437
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for trigeminal pain in mice.
Tzabazis AZ; Klukinov M; Feliciano DP; Wilson SP; Yeomans DC
Gene Ther; 2014 Apr; 21(4):422-6. PubMed ID: 24572785
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy.
Workenhe ST; Simmons G; Pol JG; Lichty BD; Halford WP; Mossman KL
Mol Ther; 2014 Jan; 22(1):123-31. PubMed ID: 24343053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
